IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) Sarcoma Groups phase I/II trial of sunitinib plus nivolumab in selected bone and soft tissue sarcoma subtypes—Results of the phase I part.

Authors

Javier Martin Broto

Javier Martin Broto

Virgen del Rocio University Hospital, Institute of Biomedicine Research (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain

Javier Martin Broto , Nadia Hindi , Andres Redondo , Javier Martinez-Trufero , Silvia Stacchiotti , Emanuela Palmerini , Enrique Alava , David Silva Moura , Herminia Perez Vega , Irene Otero , Patricio Ledesma , Emanuela Marchesi , Jose A. Lopez-Martin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03277924

Citation

J Clin Oncol 36, 2018 (suppl; abstr 11515)

DOI

10.1200/JCO.2018.36.15_suppl.11515

Abstract #

11515

Poster Bd #

260

Abstract Disclosures

Similar Posters